Australia's PolyNovo rises most in more than 2 weeks on HY revenue growth
** Shares of PolyNovo PNV.AX rise as much as 3.5% to
A$1.640, their highest since Jan. 5
** Medical device developer says HY total global revenue was
A$48.8 mln ($32.20 mln), compared with A$29.5 mln last year
** Stock posts its biggest intraday pct gain since Jan. 9
** Stock fell 18.1% last year, its worst year since 2021
($1 = 1.5154 Australian dollars)
(Reporting by Neha Soni in Bengaluru)
((Neha.Soni@thomsonreuters.com))